Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome

Leukemia

Volumn 11, Issue SUPPL. 3, 1997, Pages 533-535

  Misawa, Shinichi ^a   Horiike, Shigeo ^a   Kaneko, Hiroto ^a   Kashima, Kei ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME ANALYSIS; CODON; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; EXON; GENE MUTATION; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR SUPPRESSOR GENE;

EID: 0030812204     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Yunis JJ eu al. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndrome. Blood, 1986 1721-1730.
2. Horiike S et al. Chromosome abnormalities' and karyotypic evolution in 83 patients with myelodysplastic syndrome. Cancer, 1988; 62:1129-1138.
3. Paquett RL et al. N-ras mutations are associated with poor prognosis and risk of leukemic transformation in myelodysplastic syndrome. Blood, 1993; 82:590-599.